Stephen Bunting
Managing Partner

has more than 25 years experience of life science venture capital investment. He joined Abingworth in 1987 and became its Managing Partner in 2002. Stephen has been a Director of a number of companies in the US and Europe and was Founding Chairman of Astex Therapeutics, Devgen and Hexagen. Other directorships have included Ablynx, Aurora Biosciences and Genetic Therapy. Before joining Abingworth, he worked for N M Rothschild & Sons, the adviser to Biotechnology Investments Limited. At Abingworth he is responsible for building and leading the team and for investment strategy. He is active in UK and Continental European deals. Stephen has a PhD in Biological Sciences.